Commercially obtained Buffalo rat liver (BRL) cells were grown in monolayer culture. The effect of BRL cell coculture with assisted hatching on embryo development, implantation and pregnancy was investigated in a population of 200 'first-time' in-vitro fertilization (IVF) patients, subdivided into three groups according to the methods of fertilization [IVF; intracytoplasmic sperm injection (ICSI); ICSI/IVF]. Assisted hatching was performed on all embryos chosen for transfer. Following co-culture, the overall embryo quality, implantation rate and pregnancy rates were not significantly different from the controls. However, when grouped according to fertilization method, co-culture was found to have an impact on pregnancy and implantation rates in the group undergoing conventional IVF. Using co-culture with assisted hatching, we were able to achieve a 58% (38/65) clinical pregnancy rate with a 49% (32/65) live birth rate and a 26% (60/235) implantation rate. No changes in the pregnancy and implantation rates were apparent in ICSI or ICSI/IVF subgroups. This is the first prospective, randomly controlled study which reports the use of BRL cell co-culture for human IVF for a large number of patients undergoing IVF for the first time.
Introduction
A variety of cell types, either commercially obtained cell lines or cultured cells established from abattoir or surgical specimens, have been shown to support human embryo development in vitro. Those parameters which may affect the outcome of co-culture include type of monolayer, indication for IVF, duration of co-culture, and patient population selected (Plachot, 1996) . Bongso et al. (1992) were able to demonstrate a positive effect using human oviduct cells for a group of patients with tubal, idiopathic or male factor infertility who had failed at least two previous in-vitro fertilization (IVF) attempts. Wiemer et al. (1993) reported a significant benefit of using bovine oviduct cells, achieving better embryo develop-ment, implantation and pregnancy for non-male factor patients only. One commercially available cell line that has commonly been used in human IVF is the Vero cell (African green monkey kidney cells). Positive effects on embryo development using Vero cells have been reported by several researchers (Menezo et al., 1990; Zetova et al., 1993; Magli et al., 1995) . However, when Vero cells were used for first-time IVF patients, no effect was observed (Sakkas et al., 1994) . The Buffalo rat liver (BRL) cell co-culture system was first used on mouse one-cell embryos to overcome the two-cell block in vitro (Hu et al., 1989) . Further experiments on the effect of BRL cells on bovine embryos revealed a positive benefit on both fresh embryo development and viability following cryopreservation . The application of BRL cell co-culture for human embryos obtained from poor prognosis patients suggested positive effects on both the implantation and clinical pregnancy rates (Hu et al., 1997) . A controlled, randomized study of the effect of BRL cells on human embryos has not yet been reported. This study was designed to evaluate the effect of co-culture with BRL cells, followed by assisted hatching, on human embryo development, implantation and pregnancy rates using first-time IVF patients.
Materials and methods

Patient inclusion
The clinical application of co-culture was approved by the Internal Review Board of Northwest Medical Centre in Margate, Florida. Commercially obtained BRL cells (BRL 3A, American Type Culture Collection, Rockville, MD, USA) were screened pathologically, including for immunodeficiency virus and hepatitis, prior to the study. Informed written consent for the co-culture procedure was obtained from each patient.
First-time IVF patients, age ഛ39 years, with normal follicle stimulating hormone (FSH) concentrations (ഛ10 mIU/ml), and with male or non-male factor, were allocated randomly between treatment and control groups. Retrieved oocytes were fertilized either by conventional IVF or by intracytoplasmic sperm injection (ICSI) methods, depending on semen quality. For some patients, retrieved oocytes were fertilized by both methods (ICSI/IVF group). BRL cell monolayers in human tubal fluid (HTF) supplemented with 15% Synthetic Serum Substitute (SSS) (Irvine Scientific, Irvine, California, USA) were used for the culture of zygotes from the treatment group. For the control group, zygotes were cultured in HTF with 15% SSS alone. A total of 200 patients was randomly allocated in the study.
Monolayer preparation
Frozen BRL cells were thawed in a 37°C water bath and cultured in M199 with 10% heat-treated fetal calf serum (FCS; Life Technology, NY, USA) in 25 cm 2 tissue culture flasks. Subculture was performed weekly by trypsinizing the cells using 0.05% trypsin (Sigma, St Louis, MO, USA). To prepare the monolayer culture system, cells were plated at a density of 1ϫ10 4 per well in a four-well Nunc plate (Nunc, Germany) in M199 with 10% FCS 24 h prior to oocyte retrieval. Prior to embryo culture, M199 was replaced with 1 ml of HTF supplemented with 15% SSS.
IVF procedure
Detailed stimulation protocols have been described elsewhere (Hu et al., 1996) . Briefly, the gonadotrophin-releasing hormone agonist (GnRHa) (Lupron, Tap Pharmaceuticals, Deerfield, IL, USA) was used until pituitary down regulation was documented (Droesch et al., 1989) . The flare regimen was employed in patients having an intermenstrual interval Ͼ35 days, a mid-luteal progesterone level Ͻ5 ng/ml, or an absent luteinizing hormone (LH) surge (Garcia et al., 1990) . Ovarian stimulation was achieved with human menopausal gonadotrophin (HMG) (Pergonal) and FSH (Metrodin) (Serono Laboratories, Norwell, MA, USA) and oocyte retrieval was performed 34-36 h after human chorionic gonadotrophin (HCG) administration.
Zygotes were co-cultured with BRL cells in 1 ml HTF supplemented with 15% SSS for the treatment group. Zygotes in the control group were cultured in a droplet of 50 µl HTF with 15% SSS under oil (Squibb, Rahway, NJ, USA). All zygotes in both groups were cultured singly. After 48 h of culture, embryos with the least fragmentation and the greatest number of blastomeres were selected for transfer. All embryos underwent assisted hatching according to a non-selective procedure (Hu et al., 1996) .
Embryo grading
A scale of 1-5 was used for embryo morphological evaluation according to a modification of Veeck's classification system (Veeck, 1991) . Grade 1 represented good embryo morphology, grades 2 and 3 referred to embryos in fair condition and grades 4 and 5 referred to poor quality. The grading system used was as follows:
Grade 1 -pre-embryo with blastomeres of equal size; 0% cytoplasmic fragments. Grade 2 -pre-embryo with blastomeres of equal size; Ͻ30% cytoplasmic fragments. Grade 3 -pre-embryo with blastomeres of distinctly unequal size; 0% cytoplasmic fragments. Grade 4 -pre-embryo with blastomeres of equal or unequal size; 30-50% cytoplasmic fragments if equal or 1-50% fragments if unequal. Grade 5 -pre-embryo with less than four blastomeres of any size;
any pre-embryo with Ͼ50% cytoplasmic fragments.
Statistical analysis
The comparison of embryo quality, implantation, and pregnancy rates between treatment and control groups was performed using Student's t-test and the χ 2 -test. In a two-tailed test, P Ͻ 0.10 was considered to be statistically significant. Power analysis revealed that with~380 patients in each group, there was Ͼ90% power to detect a difference with true implantation rates of 10 and 30%. With 100 patients in each group, there was~65% power to detect a difference with true pregnancy or delivery rates of 50 and 65%.
Results
The demographics of the patients in the study are presented in Table I . No significant differences were observed between the treatment and the control groups in the number of patients, the maternal age, the fertilization rates and the number of embryos replaced per patient. BRL ϭ Buffalo rat liver, IVF ϭ in-vitro fertilization, ICSI ϭ intracytoplasmic sperm injection, NS ϭ not significant. The effect of co-culture with BRL cells followed by assisted hatching on embryo development at 72 h post-retrieval can be found in Table II . No statistically significant differences were observed in terms of blastomere proliferation and embryo fragmentation. The percentages of good, fair, or poor quality embryos produced by the two treatments were also similar. Table III shows the overall pregnancy and implantation rates achieved by BRL co-culture with assisted hatching. Clinical pregnancy is defined by the presence of at least one intrauterine sac and implantation by the number of intra-uterine sacs with cardiac activity at sonography as a percentage of the total number of embryos transferred. The clinical pregnancy, live birth and implantation rates were not significantly different between BRL treatment and control. Table IV shows the effects of co-culture on outcome after breakdown of patient groups according to method of fertilization, i.e. by ICSI, IVF or ICSI/IVF fertilization subgroups (Table IV) . No effects on pregnancy or implantation rates were shown for patients with ICSI or ICSI/IVF subgroups. However, in the IVF group, statistically significant improvements were seen in the clinical pregnancy rates (58% in BRL versus 41% in control, P ϭ 0.05) and live birth rates (49% in BRL versus 31% in control, P ϭ 0.049) per retrieval. The implantation rate in the BRL group was also significantly improved (26% in BRL versus 19% in control, P ϭ 0.001).
Discussion
BRL cells have the ability to synthesize growth factors, referred to as multiplication-stimulating activity, which consist of multiple species of polypeptides (Moses et al., 1980) . BRLconditioned medium contains a differentiation inhibiting activity that is synonymous with leukaemia inhibitory factor (LIF) (Slager et al., 1993) . In humans, LIF expression occurs in the endometrial tissue and placenta during the uterine secretory phase and plays a role in uterine function during pregnancy (Kojima et al., 1994) . This suggests that BRL cells may be able to support later stage embryo development. Previous studies showed a significant effect of BRL cells in the support of murine and bovine one-cell embryos to the blastocyst stage (Hu et al., 1989; Voelkel and Hu, 1992a) . In humans, since embryo transfer often occurs on day 3 post-retrieval, the BRL co-culture was initiated on the second day, so as to apply the system at a relatively later stage prior to embryo transfer. Despite this short period of culture, significant improvements in pregnancy (P Ͻ 0.054) and implantation (P Ͻ 0.001) rates were observed for the first-time patients following conventional fertilization. This may be due to growth factors secreted by the BRL cells during co-culture, as well as their removal of toxic components possibly released by degradation of the culture medium or by developing embryos.
The impairment in in-vivo hatching after embryo transfer has been proposed as a possible cause of implantation failure (Cohen et al., 1990) . The hatching process was more likely to be impaired in embryos with a small opening or a slit due to micromanipulation or freezing. Co-culture and assisted hatching techniques have a similar effect on improving the hatching rates of human embryos. Co-culture with human oviductal cells improved the percentage of hatching blastocysts significantly (38 versus 7%) for embryos cultured from day 1 postinsemination (Yeung et al., 1992) . A significantly higher hatching rate was also observed when a sequential human oviduct-endometrial cell co-culture system was used (Bongso et al., 1994) . Piekos et al. (1995) were also able to demonstrate a positive effect on hatching rate using human tubal epithelium 167 cells. Therefore, assisted hatching may not pose any additional hatching advantage on the zona intact embryos which underwent co-culture. On the other hand, the control embryos, especially following ICSI, may have benefited from assisted hatching. Cohen et al. (1990) reported that micromanipulated embryos obtained from couples with male problems implanted at higher rates than intact embryos after assisted hatching had been performed. The significant improvement on hatching ability of frozen-thawed embryos has also been reported after application of the PZD procedure (Mandelbaum et al., 1994; Mandelbaum, 1996) . The overall improvement in outcome following ICSI cannot be achieved by the general application of either co-culture or assisted hatching (Tucker et al., 1996) . A similar finding was obtained in the ICSI subgroup in this study, which may account for the inability to demonstrate a positive effect on pregnancy and implantation rates after co-culture.
The co-culture system has been suggested to minimize embryo fragmentation and improve blastomere proliferation (Feng et al., 1996; Wiemer et al., 1996) . Wiemer et al. (1996) demonstrated the significant effects on improving blastomere proliferation and the reduction of embryo fragmentation for patients aged ഛ39 years, those with no male factor and those undergoing ICSI. Following co-culture of embryos on human granulosa, bovine oviductal or uterine cell monolayers, Feng reported that the percentages of embryos that reached the eight-cell stage 72 h after retrieval were significantly improved. In this study, we were unable to demonstrate any effects on embryo fragmentation or blastomere proliferation for the firsttime IVF patients, either after conventional IVF or after ICSI.
In conclusion, co-culture with BRL cells followed by assisted hatching had no significant effects on overall pregnancy and implantation rates when patients receiving IVF or ICSI were evaluated together. However, the system showed a significant effect on the clinical pregnancy (P Ͻ 0.054), live birth (P Ͻ 0.049) and implantation (P Ͻ 0.001) rates in the subgroup undergoing IVF. This may validate the application of the coculture system with assisted hatching in cases of first-time IVF patients undergoing conventional IVF. Further investigation of the BRL co-culture system is still needed to define any benefits that may operate in different patient populations and at different stages of pre-embryo development.
